Novel panel identifies toxins linked to asthma and GI diseases: Melissa Snyder, Ph.D.

from Answers from the Lab · host Mayo Clinic Laboratories

(00:32) Could you provide us with a little bit of your background?(01:12) Could you give us an overview of this test and a summary of the assay?(01:40) What kind of patients should expect to have this test ordered?(04:11) Are other tests available that identify EDN activation in patients?(05:11) How do you envision physicians using this test to treat patients?(06:32) Can you expand on how the test is used in patient treatment?

Episode metadata supplied by the publisher feed · Published Jan 17, 2023

Embed this episode

Attribution link and audio player

What this episode covers

Melissa Snyder, Ph.D., explains how Mayo Clinic Laboratories' EDN panel improves the evaluation of certain patients with asthma and autoimmune digestive disorders. EDN is the first laboratory test that provides a marker of eosinophil-derived neurotoxins.

Distinct summary based on available episode metadata or transcript content.

NOW PLAYING

Novel panel identifies toxins linked to asthma and GI diseases: Melissa Snyder, Ph.D.

0:00 7:28

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Answers from the Lab?

This episode is 7 minutes long.

When was this Answers from the Lab episode published?

This episode was published on January 17, 2023.

Can I download this Answers from the Lab episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!